Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Design, recruitment and baseline characteristics of the LENS trial.

Journal article

LENS Collaborative Group None., (2024), Diabetic medicine : a journal of the British Diabetic Association

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.

Journal article

EMPA-KIDNEY Collaborative Group None., (2024), The lancet. Diabetes & endocrinology, 12, 39 - 50

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.

Journal article

EMPA-KIDNEY Collaborative Group None., (2024), The lancet. Diabetes & endocrinology, 12, 51 - 60

Independent relevance of adiposity measures to coronary heart disease risk among 0.5 million adults in UK Biobank.

Journal article

Trichia E. et al, (2023), Int J Epidemiol, 52, 1836 - 1844

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914

Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.

Journal article

Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration None., (2023), Lancet Diabetes Endocrinol

Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease

Journal article

Mayne K. et al, (2023), Journal of the American Society of Nephrology

A deep catalog of protein-coding variation in 985,830 individuals.

Journal article

Sun KY. et al, (2023), bioRxiv

Genotyping, sequencing and analysis of 140,000 adults from Mexico City.

Journal article

Ziyatdinov A. et al, (2023), Nature, 622, 784 - 793

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model

Journal article

Wu R. et al, (2023), British Journal of General Practice

Educational and social inequalities and cause-specific mortality in Mexico City: a prospective study.

Journal article

Addey T. et al, (2023), Lancet Public Health, 8, e670 - e679

Rare coding variants in CHRNB2 reduce the likelihood of smoking.

Journal article

Rajagopal VM. et al, (2023), Nat Genet

Load More